Anti-NMDA-receptor encephalitis
ICD-10 G04.8 · ICD-11 8E4A.0.3

Treatment of Anti-NMDA-receptor Encephalitis in Children with Neurologic Relapse After Herpes Simplex Encephalitis

Clinical Scenario

Children who have recovered from herpes simplex virus encephalitis (HSE) may experience a subsequent relapse of neurologic symptoms. This presentation may not represent viral recurrence but instead a post-HSE NMDA-receptor antibody encephalitis — an autoimmune condition triggered in the setting of prior HSE that demands a distinct diagnostic and management approach.

Key Comorbidity — Herpes Simplex Encephalitis

A prior episode of herpes simplex encephalitis is the defining comorbidity for this protocol. When neurologic symptoms recur or worsen after HSE, clinicians face the critical challenge of distinguishing viral recurrence from an emerging autoimmune etiology. A high index of suspicion for an underlying autoimmune cause must be maintained throughout the initial evaluation.

Approach (Partial Overview)

Initial management centres on prompt antiviral treatment while the evaluation for an autoimmune etiology proceeds in parallel. The full structured regimen — including the diagnostic criteria, escalation pathway, and complete treatment sequence — is available via the protocol below.

Instant Access to Structured Evidence-Based Regimens

References

DOI: 10.1212/NXI.0000000000001052

Patients with relapse of neurologic symptoms after HSE should be given acyclovir promptly (until HSE can be excluded based on clinical picture and negative CSF herpes simplex virus PCR), while maintaining a high index of suspicion for an underlying autoimmune etiology.

View source ↗